Clinical Trial Update: Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering). [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the efficacy and tolerability of Ecopipam in adults with childhood-onset fluency disorder (stuttering). The study spans Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood-onset Fluency Disorder
• Communication Disorder
• Language Disorders
• Speech Disorders
• Stuttering

Drugs mentioned

• Ecopipam (Ecopipam)

Snippet

Sponsor: Gerald Maguire, MD | Conditions: Stuttering, Adult, Childhood-onset Fluency Disorder | Phase 2, Phase 3 | Status: UNKNOWN